Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE4.7800
- TODAY'S CHANGE (%)-0.0300 (-0.6237%)
- Bid / Lots4.6400/ 1
- Ask / Lots4.8900/ 1
- Open / Previous Close4.8200 / 4.8100
- Day Range
- 52 Week Range
- Volume425,542
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 4272 | 4.885 |
| 09:34 ET | 200 | 4.95 |
| 09:36 ET | 1600 | 4.9299 |
| 09:38 ET | 100 | 4.93 |
| 09:39 ET | 2350 | 4.99 |
| 09:41 ET | 1005 | 5.02 |
| 09:43 ET | 895 | 5.043 |
| 09:45 ET | 6436 | 5.105 |
| 09:48 ET | 3056 | 5.1 |
| 09:50 ET | 13775 | 5.095 |
| 09:52 ET | 1200 | 5.09 |
| 09:54 ET | 1870 | 5.0524 |
| 09:56 ET | 999 | 5.02 |
| 09:57 ET | 700 | 4.9858 |
| 09:59 ET | 1900 | 4.98 |
| 10:01 ET | 550 | 4.93 |
| 10:03 ET | 165 | 4.95 |
| 10:06 ET | 411 | 4.955 |
| 10:08 ET | 17072 | 4.98 |
| 10:10 ET | 643 | 4.97 |
| 10:12 ET | 5722 | 4.94 |
| 10:14 ET | 100 | 4.94 |
| 10:15 ET | 400 | 4.94 |
| 10:17 ET | 220 | 4.94 |
| 10:21 ET | 431 | 4.95 |
| 10:24 ET | 200 | 4.96 |
| 10:26 ET | 1050 | 4.9 |
| 10:28 ET | 340 | 4.91 |
| 10:30 ET | 1305 | 4.87 |
| 10:32 ET | 2852 | 4.9 |
| 10:33 ET | 300 | 4.87 |
| 10:35 ET | 1600 | 4.85 |
| 10:37 ET | 1105 | 4.8699 |
| 10:39 ET | 2967 | 4.87 |
| 10:42 ET | 800 | 4.87 |
| 10:44 ET | 925 | 4.87 |
| 10:46 ET | 1100 | 4.84 |
| 10:48 ET | 400 | 4.82 |
| 10:50 ET | 600 | 4.83 |
| 10:51 ET | 707 | 4.8383 |
| 10:53 ET | 410 | 4.84 |
| 10:55 ET | 1826 | 4.82 |
| 10:57 ET | 2390 | 4.83 |
| 11:02 ET | 150 | 4.845 |
| 11:04 ET | 3405 | 4.84 |
| 11:08 ET | 210 | 4.84 |
| 11:09 ET | 4480 | 4.84 |
| 11:11 ET | 324 | 4.85 |
| 11:13 ET | 2300 | 4.83 |
| 11:18 ET | 1297 | 4.82 |
| 11:20 ET | 100 | 4.8 |
| 11:22 ET | 900 | 4.79 |
| 11:24 ET | 300 | 4.7701 |
| 11:26 ET | 100 | 4.77 |
| 11:29 ET | 544 | 4.76 |
| 11:31 ET | 1319 | 4.77 |
| 11:33 ET | 1325 | 4.755 |
| 11:36 ET | 728 | 4.755 |
| 11:42 ET | 100 | 4.75 |
| 11:45 ET | 6068 | 4.78 |
| 11:47 ET | 400 | 4.78 |
| 11:49 ET | 450 | 4.77 |
| 11:54 ET | 1700 | 4.77 |
| 11:56 ET | 910 | 4.76 |
| 12:00 ET | 190 | 4.76 |
| 12:02 ET | 1360 | 4.758 |
| 12:03 ET | 1025 | 4.77 |
| 12:05 ET | 214 | 4.77 |
| 12:07 ET | 516 | 4.7517 |
| 12:09 ET | 100 | 4.75 |
| 12:14 ET | 100 | 4.75 |
| 12:18 ET | 600 | 4.75 |
| 12:20 ET | 450 | 4.7346 |
| 12:23 ET | 14564 | 4.73 |
| 12:25 ET | 134 | 4.71 |
| 12:27 ET | 769 | 4.73 |
| 12:32 ET | 500 | 4.72 |
| 12:38 ET | 524 | 4.72 |
| 12:43 ET | 2500 | 4.71 |
| 12:48 ET | 744 | 4.71 |
| 12:54 ET | 1232 | 4.7 |
| 12:56 ET | 795 | 4.7 |
| 12:57 ET | 100 | 4.695 |
| 01:01 ET | 500 | 4.7 |
| 01:03 ET | 400 | 4.71 |
| 01:06 ET | 225 | 4.695 |
| 01:08 ET | 300 | 4.69 |
| 01:12 ET | 700 | 4.7 |
| 01:14 ET | 500 | 4.7 |
| 01:17 ET | 100 | 4.695 |
| 01:19 ET | 500 | 4.7 |
| 01:21 ET | 282 | 4.7 |
| 01:24 ET | 200 | 4.7 |
| 01:26 ET | 500 | 4.71 |
| 01:28 ET | 2349 | 4.71 |
| 01:30 ET | 7094 | 4.73 |
| 01:32 ET | 543 | 4.73 |
| 01:33 ET | 600 | 4.74 |
| 01:35 ET | 900 | 4.74 |
| 01:37 ET | 500 | 4.74 |
| 01:39 ET | 100 | 4.75 |
| 01:42 ET | 898 | 4.76 |
| 01:44 ET | 2932 | 4.75 |
| 01:46 ET | 2727 | 4.77 |
| 01:48 ET | 105 | 4.765 |
| 01:50 ET | 200 | 4.765 |
| 01:51 ET | 1000 | 4.79 |
| 01:53 ET | 100 | 4.79 |
| 01:55 ET | 2693 | 4.78 |
| 02:02 ET | 100 | 4.78 |
| 02:04 ET | 5301 | 4.79 |
| 02:06 ET | 801 | 4.8 |
| 02:08 ET | 1410 | 4.81 |
| 02:09 ET | 1376 | 4.82 |
| 02:11 ET | 1392 | 4.8 |
| 02:13 ET | 1200 | 4.795 |
| 02:15 ET | 166 | 4.8 |
| 02:22 ET | 288 | 4.795 |
| 02:24 ET | 200 | 4.78 |
| 02:26 ET | 500 | 4.81 |
| 02:31 ET | 1060 | 4.79 |
| 02:33 ET | 774 | 4.774 |
| 02:36 ET | 1900 | 4.7728 |
| 02:38 ET | 1306 | 4.7597 |
| 02:40 ET | 427 | 4.76 |
| 02:42 ET | 300 | 4.75 |
| 02:44 ET | 1300 | 4.77 |
| 02:45 ET | 300 | 4.77 |
| 02:47 ET | 300 | 4.7799 |
| 02:49 ET | 4523 | 4.74 |
| 02:51 ET | 300 | 4.7332 |
| 02:54 ET | 400 | 4.73 |
| 02:56 ET | 1927 | 4.73 |
| 02:58 ET | 2715 | 4.75 |
| 03:03 ET | 500 | 4.735 |
| 03:05 ET | 1400 | 4.74 |
| 03:09 ET | 200 | 4.74 |
| 03:12 ET | 200 | 4.73 |
| 03:14 ET | 100 | 4.74 |
| 03:16 ET | 825 | 4.74 |
| 03:18 ET | 300 | 4.74 |
| 03:21 ET | 200 | 4.74 |
| 03:23 ET | 200 | 4.74 |
| 03:25 ET | 200 | 4.73 |
| 03:27 ET | 303 | 4.7336 |
| 03:30 ET | 3208 | 4.73 |
| 03:32 ET | 300 | 4.73 |
| 03:34 ET | 400 | 4.72 |
| 03:36 ET | 800 | 4.73 |
| 03:38 ET | 396 | 4.72 |
| 03:39 ET | 3717 | 4.74 |
| 03:41 ET | 1454 | 4.75 |
| 03:43 ET | 1338 | 4.745 |
| 03:45 ET | 800 | 4.755 |
| 03:48 ET | 600 | 4.755 |
| 03:50 ET | 700 | 4.755 |
| 03:52 ET | 700 | 4.755 |
| 03:54 ET | 5984 | 4.79 |
| 03:56 ET | 4473 | 4.79 |
| 03:57 ET | 4301 | 4.785 |
| 03:59 ET | 4927 | 4.78 |
Yesterday
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation, from 5:42AM ET on Saturday Jun 01, 2024 by Dow Jones
5:42AM ET on Saturday Jun 01, 2024 by Dow JonesLifshitz Law PLLC Announces Investigations of Nextdoor Holdings, Inc. (NYSE: KIND), Fox Factory Holding Corp. (NASDAQ: FOXF), The Chemours Company (NYSE: CC), and Ventyx Biosciences, Inc. (NASDAQ: VTYX), from 3:36AM ET on Saturday Jun 01, 2024 by Dow Jones
3:36AM ET on Saturday Jun 01, 2024 by Dow Jones
May 30, 2024
May 29, 2024
May 20, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 337.0M | -1.5x | --- |
Zura Bio Ltd | 334.3M | -3.2x | --- |
Nautilus Biotechnology Inc | 343.2M | -5.1x | --- |
Tenaya Therapeutics Inc | 330.6M | -2.6x | --- |
Anavex Life Sciences Corp | 343.6M | -8.2x | --- |
Skye Bioscience Inc | 325.9M | -2.6x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Operating Officer
- Matthew Moore
- Chief Scientific Officer
- John Nuss
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $337.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
